BTAI

BioXcel Therapeutics, Inc. Common Stock

$1.13

+0.05 (+4.63%)

Volume:

884.006K ($1.00M)

#1265 Volume #3376 Dollar Volume

Market Capitalization:

$30.59M

#4658 Market Cap

BioXcel Therapeutics Price Chart

BioXcel Therapeutics Volume Chart

BioXcel Therapeutics Market Segments

Regular Trading Hours

-0.02(-1.74%)

Open	$1.15
Close	$1.13
Low	$1.09
Low Change	-0.06 (-5.22%)
High	$1.18
High Change	+0.03 (+2.61%)
Range	$0.09
Volume	547.498K
Dollar Volume	$618.67K

Premarket

+0.02(+1.79%)

Open	$1.12
Close	$1.14
Low	$1.12
Low Change	-0.01 (-0.45%)
High	$1.25
High Change	+0.13 (+11.61%)
Range	$0.14
Volume	336.508K
Dollar Volume	$383.62K

After Hours Yesterday

+0.06(+5.55%)

Open	$1.08
Close	$1.14
Low	$1.07
Low Change	-0.01 (-0.93%)
High	$1.15
High Change	+0.07 (+6.44%)
Range	$0.08
Volume	23.019K
Dollar Volume	$26.24K

Regular Trading Hours Yesterday

-0.06(-5.26%)

Open	$1.14
Close	$1.08
Low	$1.06
Low Change	-0.08 (-7.02%)
High	$1.15
High Change	+0.01 (+0.44%)
Range	$0.09
Volume	1.206M
Dollar Volume	$1.30M

Premarket Yesterday

+0.01(+0.88%)

Open	$1.14
Close	$1.15
Low	$1.12
Low Change	-0.02 (-1.75%)
High	$1.15
High Change	+0.01 (+0.88%)
Range	$0.03
Volume	11.679K
Dollar Volume	$13.43K

BioXcel Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$1.19
10 Day Moving Average (SMA10)	$1.26
20 Day Moving Average (SMA20)	$1.41
50 Day Moving Average (SMA50)	$1.53
100 Day Moving Average (SMA100)	$1.71
200 Day Moving Average (SMA200)	$2.25

BioXcel Therapeutics Statistics

Average Volume (30 Days)	2.41M
P/E Ratio (Current)	-.44
EPS (Current)	-$2.58
Dividend Yield	0.00%
Free Cash Flow	—
Cash Ratio	0.53
Current Ratio	0.82
Quick Ratio	0.81
Debt to Equity	-1.15
Enterprise Value	$112.04M
EV to EBITDA	-2.24
EV to Sales	174.52
Price to Book	-0.32
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	48.08
Return on Assets	-1.56%
Return on Equity	0.73%

BioXcel Therapeutics Stock Splits

There has been 1 stock split for BioXcel Therapeutics (BTAI). The reverse stock split occured on February 10, 2025 and reduced the outstanding shares at a ratio of 16:1.

Date	Type	Ratio
Feb 10, 2025	Reverse	16:1

BioXcel Therapeutics Dividends

There have been no dividends for BioXcel Therapeutics (BTAI).